Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/26/24 19:14 | 1/25/24 | ACET | Health | Drug | Pharmaceutical Preparations | Orbimed Advisors LLC | NY | DT | 1 | P | 7,500 | 2.40 | 0 | 3,125 | 2,931 | I | ||||||||||||||||
1/26/24 19:13 | 1/25/24 | ACET | Health | Drug | Pharmaceutical Preparations | Gordon Carl L | MA | DT | 1 | P | 7,500 | 2.40 | 0 | 3,125 | 2,931 | I | ||||||||||||||||
10/2/23 20:16 | 9/28/23 | ACET | Health | Drug | Pharmaceutical Preparations | Schor Chen | MA | DO | P,CEO | 1 | P.m | 15 | 1.38 | 0 | 11 | 5 | 251 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |